Human skin-derived mast cells can proliferate while retaining their characteristic functional and protease phenotypes

被引:99
作者
Kambe, N
Kambe, M
Kochan, JP
Schwartz, LB
机构
[1] Virginia Commonwealth Univ, Dept Internal Med, Div Rheumatol Allergy & Immunol, Richmond, VA 23298 USA
[2] Hoffmann La Roche Inc, Dept Metab Dis, Nutley, NJ 07110 USA
关键词
D O I
10.1182/blood.V97.7.2045
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Human mast cells in adult tissues have been thought to have limited, if any, proliferative potential. The current study examined mast cells obtained from adult skin and cultured in serum-free medium with recombinant human stem cell factor. During the first 4 weeks of culture, the percentages of mast cells increased from 10 to almost 100. After 8 weeks, a 150-fold increase in the number of mast cells was observed. When freshly dispersed mast cells were individually sorted onto human fibroblast monolayers and cultured for 3 weeks, one or more mast cells were detected in about two thirds of the wells, and in about two thirds of these wells the surviving mast cells showed evidence of proliferation, indicating most mast cells in skin can proliferate. Such mast cells all expressed high surface levels of Kit and Fc epsilon RI, each of which were functional, indicating IgE was not required for Fc epsilon RI expression on mast cells. Such mast cells also retained the MCTC protease phenotype of mast cells that normally reside in the dermis. After 4 to 8 weeks of culture these mast cells degranulated in response to substance P and compound 48/80, characteristics of skin-derived mast cells that persist outside of the cutaneous microenvironment. (Blood, 2001;97:2045-2052) (C) 2001 by The American Society of Hematology.
引用
收藏
页码:2045 / 2052
页数:8
相关论文
共 58 条
[1]  
Baghestanian M, 1996, EXP HEMATOL, V24, P1377
[2]   IMMUNOHISTOLOGY OF THE NASAL-MUCOSA IN SEASONAL ALLERGIC RHINITIS - INCREASES IN ACTIVATED EOSINOPHILS AND EPITHELIAL MAST-CELLS [J].
BENTLEY, AM ;
JACOBSON, MR ;
CUMBERWORTH, V ;
BARKANS, JR ;
MOQBEL, R ;
SCHWARTZ, LB ;
IRANI, AMA ;
KAY, AB ;
DURHAM, SR .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1992, 89 (04) :877-883
[3]  
BENYON RC, 1987, J IMMUNOL, V138, P861
[4]  
Buckley MG, 1999, J PATHOL, V189, P138, DOI 10.1002/(SICI)1096-9896(199909)189:1<138::AID-PATH400>3.0.CO
[5]  
2-H
[6]  
CHURCH MK, 1982, J IMMUNOL, V129, P2116
[7]   Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo [J].
Costa, JJ ;
Demetri, GD ;
Harrist, TJ ;
Dvorak, AM ;
Hayes, DF ;
Merica, EA ;
Menchaca, DM ;
Gringeri, AJ ;
Schwartz, LB ;
Galli, SJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (06) :2681-2686
[8]  
CRAIG SS, 1988, LAB INVEST, V58, P682
[9]  
FOX CC, 1985, J IMMUNOL, V135, P483
[10]  
GIBSON PG, 1993, AM REV RESPIR DIS, V148, P80, DOI 10.1164/ajrccm/148.1.80